BioMed Research International

BioMed Research International / 2003 / Article
Special Issue

Gene Therapy — Part II

View this Special Issue

Review article | Open Access

Volume 2003 |Article ID 492073 |

Kate L. Dishart, Lorraine M. Work, Laura Denby, Andrew H. Baker, "Gene Therapy for Cardiovascular Disease", BioMed Research International, vol. 2003, Article ID 492073, 11 pages, 2003.

Gene Therapy for Cardiovascular Disease

Received05 Jun 2002
Accepted19 Jul 2002


The last decade has seen substantial advances in the development of gene therapy strategies and vector technology for the treatment of a diverse number of diseases, with a view to translating the successes observed in animal models into the clinic. Perhaps the overwhelming drive for the increase in vascular gene transfer studies is the current lack of successful long-term pharmacological treatments for complex cardiovascular diseases. The increase in cardiovascular disease to epidemic proportions has also led many to conclude that drug therapy may have reached a plateau in its efficacy and that gene therapy may represent a realistic solution to a long-term problem. Here, we discuss gene delivery approaches and target diseases.

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.